Best Grants for Cancer Nonprofits in Arizona

The ASTRO-AstraZeneca SCLC Therapy Challenge RFP aims to enhance research on limited-stage small cell lung cancer (LS-SCLC) through innovative combination therapies, particularly integrating immunotherapy with advanced radiation techniques. Proposals are encouraged to explore various aspects, including care patterns, treatment workflows, prognostic biomarkers, and toxicity management. The target budget for projects ranges from $175,000 to $375,000, with consideration given to higher requests based on scientific merit, fostering significant advancements in radiation oncology.

The RFA: Biology to Prevention Award (CRUK) aims to foster innovative translational research that enhances understanding of cancer biology, ultimately leading to effective prevention strategies. Joint applications from UK and US research teams are encouraged, with a focus on equal partnerships and complementary expertise. The funding provides up to £600,000 for UK costs and up to $946,000 for US costs, supporting projects of 1 to 5 years duration that address critical research questions in cancer prevention.

The Anna Fuller Fund Grant provides year-round support for organizations dedicated to alleviating suffering caused by cancer. Established in memory of Egbert C. Fuller’s wife, the fund prioritizes applications that focus on cancer research and education initiatives. Eligible applicants must be 501(c)(3) organizations or equivalent charities outside the U.S. Grant funds cannot be used for direct treatment, ensuring that resources are allocated to research and public education.

The James Paul Sutton Medical Research Fund Grant supports non-profit organizations engaged in cancer and medical research, established through a trust by the Sutton family. Eligible organizations must be 501(c)(3) exempt. Preference is given to cancer research initiatives, while grants are not available for individuals, political groups, or for-profit entities. This fund aims to sustain medical research efforts for the long term, continuing the legacy of the Sutton family.

The National Cancer Institute (NCI) plans to issue a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award in Clinical Oncology (K12). This program aims to enhance training for clinician-scientists in cancer research, fostering their career development and collaboration with basic research scientists. It mandates diverse oncology specialties in faculty, individualized career development plans, and mentorship, supporting Scholars for up to three years to promote their research initiatives in clinical trials.

The Simeon J. Fortin Charitable Foundation, founded in 1986, champions cancer research initiatives aimed at finding a cure. It supports relevant projects and fellowships within medical and research institutions, ensuring a significant impact on health-related research. The grant review process is conducted by The Medical Foundation, in coordination with the King Trust Postdoctoral Fellowships, enhancing collaboration and funding opportunities for innovative research in oncology.

The AGD Foundation Grant Program supports nonprofit organizations in the U.S. and Canada that provide free oral cancer screenings and education, particularly for underserved communities. Established in 1972, the AGD Foundation aims to enhance public oral health and raise awareness about oral/oropharyngeal cancer. By promoting early detection and education, the foundation seeks to improve survival rates and empower communities. Eligible applicants must be 501(c)(3) organizations demonstrating a commitment to community health.

The EMF SAMFund Financial Assistance Grants support young adult cancer survivors facing financial hardships due to their diagnosis. With 80,000 young adults diagnosed with cancer each year in the U.S., these grants provide critical assistance for essential living expenses like rent, car payments, and education. By prioritizing applicants who demonstrate financial need and articulate how the grant will aid their recovery, the program aims to alleviate financial toxicity and empower survivors to move forward with their lives.

The EMF Family Building Grants, offered by the Expect Miracles Foundation, support young adult cancer survivors in their fertility treatment and family-building efforts. These grants are designed for applicants with a clear family-building plan and financial strategy, helping bridge the gap in costs associated with fertility preservation, assisted reproductive technologies, and related services. By prioritizing those actively engaged in their journey, the foundation aims to empower survivors to pursue their dreams of family.

Individuals being treated for Waldenstrom macroglobulinemia in Arizona can apply for HealthWell Foundation’s Waldenstrom Macroglobulinemia Fund; awards up to US $8,000 for prescription drug copays and Medicare Part B insurance premiums. Patients must be underinsured, receiving treatment in the U.S., have qualifying insurance, and meet income guidelines tied to the Federal Poverty Level.

Cancer researchers at U.S. academic institutions or eligible nonprofits, including those in Arizona, can seek more than US $135,000 from the American Cancer Society and Fanconi Cancer Foundation for high-risk, high-reward translational projects. Funding supports innovative work to improve detection, prevention, or treatment of cancers in individuals with Fanconi anemia.

Individuals being treated for mantle cell lymphoma in Arizona can receive help with prescription drug copays and Medicare Part B premiums through this fund. Grants from Healthwell Foundation help U.S. patients with insurance and incomes within 300–500% of the Federal Poverty Level cover treatment-related out-of-pocket costs, with awards up to US $8,500.

Underinsured U.S. patients being treated for chronic lymphocytic leukemia can receive up to US $8,000 to cover prescription drug copays and Medicare Part B insurance premiums. With a mission to reduce financial barriers to care, Healthwell Foundation provides nationwide cancer and leukemia patients with support for high-cost medications listed under this disease-specific fund.

Individuals being treated for cancer-related behavioral health conditions in Arizona and across the U.S. can receive up to US $2,000 to offset prescription copays, counseling, psychotherapy, and related transportation costs. The Healthwell Foundation supports underinsured patients whose income and insurance status meet its guidelines, helping reduce financial barriers to essential behavioral health care.

Underinsured patients being treated for amyloidosis in the U.S., including Arizona, can receive up to US $8,000 to cover prescription drug copays and Medicare Part B premiums. The Healthwell Foundation supports individuals whose insurance covers part of their cancer-related medications and whose household income falls within its federal poverty level guidelines.

Professional elderly blues musicians in Arizona facing emergency medical or basic living expenses can receive US $500 in assistance for needs like treatment, transportation, home care, utilities, or burial costs. The Pinetop Perkins Foundation pays creditors directly, and artists dealing with cancer-related or other serious health crises may be eligible if income and age requirements are met.

Nonprofit and other eligible U.S. organizations conducting cancer/oncology comparative clinical effectiveness research can apply for up to US $13,000,000 to improve care across the cancer continuum. With a mission to support patient-centered research, Patient-Centered Outcomes Research Institute provides funding for projects addressing screening barriers, treatment delivery, and survivorship needs, including work benefiting Arizona communities.

Arizona cancer and health research organizations can access funding through the Patient-Centered Outcomes Research Institute for retrospective observational comparative effectiveness studies using existing data sources. Eligible public and private sector entities must focus on at least one approved topic, such as addressing cancer, maternal morbidity and mortality, mental and behavioral health, or rare diseases, with awards up to US $2,000,000.

Cancer research institutions and academic medical centers conducting translational oncology studies in the U.S. and territories, including Arizona, can seek funding to advance prevention, early detection, diagnosis, and treatment of organ-specific or biologically related cancers. National Institutes of Health SPORE P50 center grants support state-of-the-art, human biology–based projects that reach a translational human endpoint within the grant period.

Graduating high school seniors and healthcare professionals pursuing oncology or hematology education in Central or Southern Illinois can receive tuition or professional development support, including certifications and conferences. Heart of Illinois Community Foundation’s Cancer Care Specialists of Illinois Scholarship reviews applications monthly for residents of Macon, Moultrie, or Piatt County with a minimum 3.0 GPA.

Full-time radiation oncology faculty clinicians conducting cancer research in Arizona can seek multi-year career development support through this clinician scientist award. Focused on advancing cancer and radiation oncology research, the American Society for Radiation Oncology and American Cancer Society provide US $135,000 annually to help clinicians build independent research careers while maintaining clinical practice.

Practicing radiation oncologists conducting cancer research in the U.S., including those based in Arizona, can apply for the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Award, which provides US $729,000 over three to five years for research across the cancer continuum. This award from the American Society for Radiation Oncology supports clinician-scientists advancing oncology care.

The National Cancer Institute (NCI) is set to release a Notice of Funding Opportunity (NOFO) aimed at advancing informatics technologies for cancer research. This initiative will support the development of tools that enhance data acquisition, management, and analysis throughout the cancer continuum. By focusing on technologies with proven impact, the NOFO seeks to optimize and sustain resources critical for cancer biology, diagnosis, treatment, and epidemiology.

Marion Community Foundation

Since 1998, area residents have been turning to Marion Community Foundation to make their philanthropic giving as effective as possible. We are a public charity serving thousands of people who share a common concern … improving the quality of life in Marion County. We use distributions from the more than 500 charitable funds — created by generous, local donors — to award more than $2.5 million in grants and scholarships each year to many of the humanitarian, educational and cultural organizations in this remarkable community we call home.

Marion Community Foundation is the area’s leading philanthropic organization, providing charitable donors the opportunity to easily create endowment funds to benefit and support our community through grants and scholarships. We serve communities throughout Marion County through philanthropy, leadership, and civic engagement.

Alex Cooper Memorial Scholarship

The Alex Cooper Memorial Scholarship Fund was created in 2017 by Jonathan Culler, his high school classmate and teammate, Andrea Ault, his devoted mother who never left his side, and the River Valley Class of 2017, after he lost a 3-year battle to childhood cancer, osteosarcoma.     

The Cooper Fund supports seniors and graduates from the River Valley Local Schools district. Alex’s scholarship gives special consideration to students active in River Valley athletics, especially football or baseball, and/or music. To honor Alex’s untimely passing, the Cooper Fund seeks to assist students who have been diagnosed with cancer personally, those with an immediate family member with the disease, and those who demonstrate financial need resulting from cancer treatment.

Rapid Cancer Grants

Fast Funding for Home Cancer Care Research

We fund healthcare researchers to rapidly explore the feasibility of home infusion as a solution to the ongoing challenges of capacity shortage, site of care management, and financial toxicity in cancer care.

Traditional funding pathways for new care models are too slow to impact patients, so we’ve streamlined the process. By providing funding approvals within 14 days, we enable healthcare teams to quickly launch and evaluate home-based cancer care programs that improve access and affordability.  

What can a Rapid Cancer Grant be used for?

Projects must comprise of research investigating the feasibility, safety, or economic benefit of cancer care at home and must include delivering care to patients via an IRB approved study. IRB approval may be obtained after grant approval. Projects may include assessing suitability of home infusion, enabling access to lab draws at home, or remote care co-ordination to reduce time toxicity for patients.

If you’re a healthcare worker at an oncology practice, hospital or academic institution in the United States and are interested in continuing or launching a new home cancer care initiative, we invite you to apply for a Rapid Cancer Grant.

We are Revolutionaries

Who We Are

We are Revolutionaries -passionate in our singular pursuit of discovering, developing and delivering innovative targeted therapies for patients living with RAS-addicted cancer. At Revolution Medicines, we believe in challenging the status quo to find new therapeutic approaches to some of the toughest cancers. With our first wave of investigational RAS(ON) inhibitors, we are pioneering a new way of targeting the RAS cancer drivers of disease, and we have the potential to change the treatment paradigm in these cancers where there is a significant unmet medical need.

Our mission is to revolutionize treatment for patients with RAS-addicted cancers through the discovery, development and delivery of innovative, targeted medicines.

Research, Grants & Support

At Revolution Medicines, we understand the importance of extending our support of scientific advancement beyond the research we conduct and the medicines we provide.

We support activities that make meaningful information and resources available to the broader medical and scientific communities to help advance science, increase understanding of certain diseases, and enhance patient care.

Charitable Donations

Funding for programs that deliver disease awareness, treatment education, or other healthcare information intended to improve patient understanding and empowerment.

Syndax Pharmaceuticals, Inc.

At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. We believe that it takes a community to build a great medicine, and that is why we are working to set the new standard for developing medicines in the field of oncology – one that revolves around collaboration, shared learning, and excellence.

Syndax’s mission is to obtain regulatory approval and commercialize drugs that extend and improve the lives of cancer patients by drawing on the newest scientific research and advances, collaborating with determined problem solvers, and identifying value in overlooked aspects of science.

Educational Funding

At Syndax, we are committed to the goal of supporting objective, balanced and scientifically rigorous education that furthers improvements in science, medicine, and patient care. We accomplish this goal, in part, by providing grants for independent medical education (IME) programs. These can include live, online, and/or enduring programs that educate healthcare providers (HCPs), patients, or caregivers. Programs that are funded via Syndax medical education grants must be primarily dedicated, in both effort and time, to medical, health or scientific topics that are objective, balanced, unbiased, and scientifically rigorous. Medical education grants must never be made with the intent to directly or indirectly reward, influence or encourage the recipient to prescribe, purchase, sell or arrange for any Syndax product.